Study ID: PM014
Study Title
- A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtecֲ®) or Placebo Prior to Daily Injections of Copaxoneֲ®.
Teva Identifier
- PM014
ClinicalTrials.gov Identifier
- NCT00240032
Study Status
- Completed
Trial Condition(s)
- Multiple Sclerosis
Interventions
- Drug: glatiramer acetate injection with oral cetirizine hydrochloride | Drug: glatiramer acetate with placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 10/01/2004 - 07/01/2006
Phase
- Phase 4
Study Type
Interventional
